Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tikly

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 9, 2014
Call for closure of Folateng private wards in public hospitals in southern GautengK R L Huddle, T Parbhoo, D Blumsohn, et al.
Rheumatology (Oxford, England)|July 11, 2000
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritisP Emery, F C Breedveld, E M Lemmel, et al.
Scandinavian Journal of Rheumatology|July 25, 2018
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) databaseP E Carreira, L Carmona, B E Joven, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 9, 2014
Call for closure of Folateng private wards in public hospitals in southern GautengK R L Huddle, T Parbhoo, D Blumsohn, et al.
Rheumatology (Oxford, England)|July 11, 2000
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritisP Emery, F C Breedveld, E M Lemmel, et al.
Scandinavian Journal of Rheumatology|July 25, 2018
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) databaseP E Carreira, L Carmona, B E Joven, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 5